Home » Topics » Regulatory » EMA

EMA
RSS

European CHMP recommends approval of Aubagio for relapsing-remitting MS

March 25, 2013

Stribild gets positive opinion in Europe

March 25, 2013

CHMP issues positive opinion on HyQvia

March 25, 2013

BioChaperone PDGF-BB to enter phase III development

March 21, 2013

Pegasys receives E.U. approval for HCV in children 5 years of age and older

March 19, 2013

Activartis gives update on its anticancer immune therapy for glioma

March 14, 2013

Roche obtains E.U. approval for Perjeta

March 6, 2013

EMA grants orphan drug status to Prothena's candidate for amyloid light-chain amyloidosis

March 5, 2013

EMA recommends approval of Sanofi Pasteur pediatric vaccine

Feb. 27, 2013

EMA confirms decision on VIVUS' MAA for obesity treatment

Feb. 25, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...